Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TFG pseudogene 1 (TFGP1) is annotated as a human pseudogene related to the functional TRK-fused gene (TFG), which encodes a conserved regulator of protein secretion and trafficking between the endoplasmic reticulum (ER) and Golgi apparatus[2]. However, as a pseudogene, TFGP1 does not encode a functional protein product, is not involved in cellular signaling or trafficking, and is not considered a therapeutic target. Research, including biochemical and disease studies, focuses on the protein-coding TFG gene, which has roles in ER-to-Golgi vesicle transport, protein secretion, and, through oncogenic gene fusions, cancer pathogenesis[3][5]. The pseudogene itself has no confirmed biological or pathological significance. If a therapeutic context is required, inquiries should be directed to the canonical, protein-coding TFG gene, not its pseudogene derivative.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TFG pseudogene 1 (TFGP1).